TMCI:NASDAQ
Treace Medical Concepts, Inc
US$1.80
arrow_downward
-0.55%(-0.0100) 1D
5월 1일, 오후 2시 1분 52초 GMT-4 · USD
search
모든 종목 코드
1D
5D
1M
6M
YTD
1Y
5Y
최대
| 종목 코드 | 가격 | 변동 | 변동률(%) |
|---|
insights_autoTMCI의 주요 통계 생성 중...
시가
US$1.82
고가
US$1.88
저가
US$1.74
시가총액
1.17억
평균 거래량
88.65만
거래량
12.63만
52주 최고가
US$7.78
52주 최저가
US$1.17
EPS
-US$0.93
베타
0.88
유통 주식수
6478.40만
직원 수
450
뉴스 기사
웹 소스 기반
프로필
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
Treace Medical Concepts, Inc에 관한 정보